5 things to know about cervical cancer

Share This Post

Cancer experts at the City of Hope, California Center for Cancer Therapy and Research, said that in fact, the more women know about the disease, the greater the chance they can prevent it.

Experts point out that in the past 40 years, the mortality rate of cervical cancer has dropped by more than 50%, because women have learned more about the risks, and more and more cervical cancer patients have undergone cervical smears, which can help doctors Screen for this disease.

However, since this type of cancer often shows no warning signs, City of Hope urges women to protect their health by understanding five aspects of cervical cancer:

1. The most common cause is human papillomavirus (HPV). About 99% of cervical cancers are caused by this sexually transmitted infection. The most common strains of the virus, HPV16 and HPV18, account for about 70% of all cases. About 14 million new HPV infections are discovered every year. Some mild, but persistent infections can cause serious health problems.

2. Cervical cancer is often preventable. The US Food and Drug Administration has approved three HPV vaccines. The first is Gardasil approved in 2006 to prevent HPV16 and HPV18. In 2009, the FDA approved Cervarix. The third vaccine, Gardasil 9, is believed to have been approved in 2014. The vaccine is 97% effective in preventing cervical cancer, vulvar cancer, and vaginal cancer, as well as preventing other types of high-risk HPV strains. It is recommended that young men and women 9 to 26 years old be vaccinated against HPV.

3. Lesbian and bisexual women are unlikely to undergo cervical cancer screening. The City of Hope indicates that this may be due to fear of discrimination and insufficient awareness of cervical cancer.

4. All women over 21 years of age should be regularly checked and screened. This should include annual pelvic examinations and regular Pap tests, which are routine screenings for cervical cancer. For Pap tests, cells are collected from the cervix to check for any abnormalities. Women over the age of 20 should undergo a Pap test every three years. Women between the ages of 30 and 64 should undergo a Pap test every five years.

5. Warning signs of cervical cancer may be scarce. Cervical cancer may cause bleeding, but many women have irregular menstruation, so they are easily overlooked. Usually, the disease does not cause pain or other obvious warning signs, making screening more important. Women should not ignore any abnormal symptoms and seek medical evaluation in a timely manner.

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

Lutetium Lu 177 dotatate is approved by USFDA for pediatric patients 12 years and older with GEP-NETS

Lutetium Lu 177 dotatate is approved by USFDA for pediatric patients 12 years and older with GEP-NETS

Lutetium Lu 177 dotatate, a groundbreaking treatment, has recently received approval from the US Food and Drug Administration (FDA) for pediatric patients, marking a significant milestone in pediatric oncology. This approval represents a beacon of hope for children battling neuroendocrine tumors (NETs), a rare but challenging form of cancer that often proves resistant to conventional therapies.

Nogapendekin alfa inbakicept-pmln is approved by the USFDA for BCG-unresponsive non-muscle invasive bladder cancer
Bladder cancer

Nogapendekin alfa inbakicept-pmln is approved by the USFDA for BCG-unresponsive non-muscle invasive bladder cancer

“Nogapendekin Alfa Inbakicept-PMLN, a novel immunotherapy, shows promise in treating bladder cancer when combined with BCG therapy. This innovative approach targets specific cancer markers while leveraging the immune system’s response, enhancing the efficacy of traditional treatments like BCG. Clinical trials reveal encouraging results, indicating improved patient outcomes and potential advancements in bladder cancer management. The synergy between Nogapendekin Alfa Inbakicept-PMLN and BCG heralds a new era in bladder cancer treatment.”

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) Cancer treatment abroad?
2) CAR T-Cell therapy
3) Cancer vaccine
4) Online video consultation
5) Proton therapy